Chief Research Officer
Chief Research Officer at Travere Therapeutics, Inc., filing insider transactions between 2026-09-15 and 2026-09-16.
| SEC ↗ |
| 2026-09-15 | TVTX | Sale | 29.0K | $62.66 | $1.8M | SEC ↗ |
| 2026-09-15 | TVTX | Sale | 3,000 | $63.65 | $191K | SEC ↗ |
| 2026-09-15 | TVTX | Sale | 270 | $65.31 | $18K | SEC ↗ |